⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EOLS News
Evolus, Inc. Common Stock
Evolus Announces Commercial Launch of Estyme ® Injectable Hyaluronic Acid Gels in Europe
businesswire.com
EOLS
Form 8-K
sec.gov
EOLS
Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year Outlook
businesswire.com
EOLS
Evolus to Report First Quarter Financial Results on May 4, 2026
businesswire.com
EOLS
Telix Appoints David Gill as Non-Executive Director
globenewswire.com
TLX
EOLS
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
EOLS
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
EOLS
Form 8-K
sec.gov
EOLS
AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting
globenewswire.com
AEON
EOLS
Form 8-K
sec.gov
EOLS